VARIAN MEDICAL SYSTEMS, INC. (NYSE:VAR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.
On October 3, 2018, Varian Medical Systems, Inc. (the “Company”) announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (“VOS”) to a new role as president of the Proton Solutions division and chief growth officer. Chris Toth, formerly president of Global Commercial & Field Operations, will succeed Kennedy as the new president of VOS. Both executives will report directly to Dow Wilson, Varian’s president and chief executive officer and both changes are effective immediately. A copy of the press release is attached as Exhibit 99.1.
|Item 9.01.||Financial Statements and Exhibits|
VARIAN MEDICAL SYSTEMS INC ExhibitEX-99.1 2 tv504148_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Press Contact Mark Plungy Director,…To view the full exhibit click
About VARIAN MEDICAL SYSTEMS, INC. (NYSE:VAR)
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions. The Company is an also a supplier of X-ray imaging components. It operates through two segments: Oncology Systems and Imaging Components. The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy and treatments, and brachytherapy, as well as informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for cancer clinics, radiotherapy centers and medical oncology practices. The Imaging Components segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer-aided diagnostics and industrial applications.